News

PhRMA: 215 drugs under development for cardiovascular disease

BY Alaric DeArment

WASHINGTON — More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.

The Pharmaceutical Research and Manufacturers of America announced Wednesday the release of a report showing that 215 drugs are under development for heart disease and stroke. More than 83 million Americans have at least one type of cardiovascular disease, and a person in the United States dies from it every 39 seconds, according to the American Heart Association.

"Safe and effective medicines that control blood pressure and lower cholesterol have helped to significantly reduce deaths from heart disease," PhRMA president and CEO John Castellani said. "The cardiovascular therapies in the pipeline reflect the commitment of America’s biopharmaceutical research companies to build on the progress made to date and help patients lead longer and healthier lives."

The drugs under development — all of them in clinical trials or under review by the Food and Drug Administration — include 30 for heart failure, 29 for lipid disorders, 19 for stroke and 17 for high blood pressure. 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

New Salese lozenges look to ease symptoms of those who suffer dry mouth

BY Jason Owen

Santa Clara, Calif. — Nuvora Inc. announced today the availability of a new soft lozenge to help provide relief for those who suffer from dry mouth.

Salese is a sugar-free and alcohol-free lozenge with Nuvora’s patented SuRe (sustained release) delivery system, which enables the lozenge to relieve dry mouth for one hour or longer, the company stated. The SuRe technology allows the lozenge to dissolve slower and release active ingredients at a more sustained rate than such traditional dry mouth products as toothpastes, mouthwash and chewing gum, which may last only minutes, the company said. The technology is designed to also neutralize acid pH levels, killing 99.9% of bacteria and helping to eliminate germs that may cause bad breath.

Dry mouth is caused by a lack of saliva production, which can occur as a side effect of numerous prescription and over-the-counter medications for pain, allergies, Parkinson’s, Alzheimer’s and diabetes, as well as a symptom of Sjoren’s Syndrome and Lupus, the company stated. Dry mouth is also common in cancer patients undergoing radiation therapy around the head and neck. Drinking plenty of water, chewing sugar-free gum or sucking on sugar-free hard candy are helpful ways to stimulate saliva production, but may be short lived, the company stated.

“For someone who suffers from dry mouth on a daily basis, a few minutes of relief just isn’t enough,” explains Bolko Stolberg, EVP of Nuvora Inc., creator of Salese. “With this unique patented technology, we can now offer longer lasting relief to not only provide comfort to dry mouth sufferers but to improve the overall health of the mouth and gums — helping to combat tooth decay, inflammations and other serious oral infections from developing.”

Salese’s key ingredients include Xanthan gum —  which locks in moisture —  essential oils and Xylitol that help to destroy bacteria and prevent tooth decay, sodium bicarbonate to help neutralize pH levels to protect tooth enamel and zinc to prevent bad breath.

Salese is available for $5.99 in peppermint and wintergreen flavors at DrugStore.com, Walgreens.com and ShopRite.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Consumer Goods Forum appoints Ahold CEO as co-chairman

BY Alaric DeArment

AMSTERDAM — An industry network of 400 retailers, manufacturers and other companies has appointed the head of Dutch supermarket operator Royal Ahold to an executive position.

The Consumer Goods Forum announced Wednesday the appointment of Ahold CEO Dick Boer as co-chairman following the meeting of its board of directors in Tokyo. The other co-chairman is Nestle CEO Paul Bulcke, and the two will replace outgoing chairman Muhtar Kent, chairman and CEO of the Coca-Cola Co., and Gareth Ackerman, chairman of Pick ‘n’ Pay. The board of the CGF, a group founded in 2009, comprises 50 leaders of retail and manufacturing companies.

"Ahold has been working with the CGF for many years, and we are honored to be involved at such a high level now," Boer said. "The CGF is uniquely positioned to drive the vision of the industry and encourage real change. Its ability to bring companies together for the good of our customers makes the work of the CGF both relevant and important."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?